Skip to main content
HR 2119 115th Congress House Commerce Civil actions and liability Consumer affairs Marketing and advertising Mental health Sex and reproductive health Sex, gender, sexual orientation discrimination Social work, volunteer service, charitable organizations State and local government operations

Therapeutic Fraud Prevention Act of 2017

Introduced: June 26, 2018 Introduced by: Lieu, Ted Democratic · California See on congress.gov
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 28, 2017
Referred to the Subcommittee on Digital Commerce and Consumer Protection.
Apr 25, 2017
Referred to the House Committee on Energy and Commerce.
Apr 25, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Therapeutic Fraud Prevention Act of 2017

This bill prohibits sexual orientation or gender identity conversion therapy from being provided in exchange for monetary compensation. It bars advertisements for such therapy that claim to: (1) change an individual's sexual orientation or gender identity, (2) eliminate or reduce sexual or romantic attractions or feelings toward individuals of the same gender, or (3) be harmless or without risk.

Individuals or entities shall not assist or facilitate a conversion therapy if they receive monetary compensation from any source in connection with providing such therapies.

These prohibitions are inapplicable to practices or treatments that do not seek to change sexual orientation or gender identity if they provide: (1) assistance to an individual undergoing a gender transition; or (2) acceptance, support, and understanding of clients or facilitation of clients' coping, social support, and identity exploration and development, including sexual orientation-neutral interventions to prevent or address unlawful conduct or unsafe sexual practices.

The Federal Trade Commission and states are provided authority to enforce against violations.

What's happening now April 28, 2017

Referred to the Subcommittee on Digital Commerce and Consumer Protection.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 108
D
Morelle, Joseph D.
New York · Dec 21, 2018
D
Costa, Jim
California · Dec 12, 2018
D
Waters, Maxine
California · Dec 12, 2018
CAPUANO, MICHAEL
· Oct 9, 2018
D
Larson, John B.
Connecticut · Sep 28, 2018
D
Boyle, Brendan F.
Pennsylvania · Sep 26, 2018
D
Correa, J. Luis
California · Sep 26, 2018
D
Evans, Dwight
Pennsylvania · Sep 26, 2018
D
Kelly, Robin L.
Illinois · Sep 25, 2018
CROWLEY, JOSEPH
· Sep 20, 2018
D
DeLauro, Rosa L.
Connecticut · Sep 20, 2018
D
Dingell, Debbie
Michigan · Sep 20, 2018
D
Gottheimer, Josh
New Jersey · Sep 20, 2018
Hanabusa, Colleen
· Sep 20, 2018
D
Jeffries, Hakeem S.
New York · Sep 20, 2018
D
Johnson, Henry C. "Hank"
Georgia · Sep 20, 2018
Lamb, Conor
· Sep 20, 2018
D
Neal, Richard E.
Massachusetts · Sep 20, 2018
Shea-Porter, Carol
· Sep 20, 2018
D
Suozzi, Thomas R.
New York · Sep 20, 2018
D
Thompson, Bennie G.
Mississippi · Sep 20, 2018
D
Veasey, Marc A.
Texas · Sep 20, 2018
D
Bera, Ami
California · Sep 17, 2018
D
Carson, André
Indiana · Sep 17, 2018
D
Castro, Joaquin
Texas · Sep 17, 2018
D
Doggett, Lloyd
Texas · Sep 17, 2018
D
Garamendi, John
California · Sep 17, 2018
D
Hoyer, Steny H.
Maryland · Sep 17, 2018
D
Sherman, Brad
California · Sep 17, 2018
Delaney, John
· Sep 13, 2018
D
Khanna, Ro
California · Sep 13, 2018
D
Norcross, Donald
New Jersey · Sep 13, 2018
D
Raskin, Jamie
Maryland · Sep 13, 2018
D
Ruiz, Raul
California · Sep 13, 2018
D
Torres, Norma J.
California · Sep 13, 2018
D
Vargas, Juan
California · Sep 13, 2018
D
Barragán, Nanette Diaz
California · Sep 12, 2018
D
Frankel, Lois
Florida · Sep 12, 2018
D
Kaptur, Marcy
Ohio · Sep 12, 2018
Kihuen, Ruben
· Sep 12, 2018
D
Thompson, Mike
California · Sep 12, 2018
BRADY, ROBERT
· Jun 26, 2018
D
Gomez, Jimmy
California · Jun 8, 2018
D
Adams, Alma S.
North Carolina · Jan 17, 2018
Walz, Timothy
· Jan 17, 2018
D
Sánchez, Linda T.
California · Oct 24, 2017
D
Soto, Darren
Florida · Aug 18, 2017
D
Schneider, Bradley Scott
Illinois · Jul 19, 2017
D
Beatty, Joyce
Ohio · Jun 13, 2017
D
Lofgren, Zoe
California · Jun 13, 2017
Page 1 of 3 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2119: Therapeutic Fraud Prevention Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2119/
MLA
"H.R. 2119: Therapeutic Fraud Prevention Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2119/.
Bluebook (legal)
H.R. 2119, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2119/.
Markdown link
[H.R. 2119: Therapeutic Fraud Prevention Act of 2017](https://openamerica.io/bill/115-HR-2119/)
Report a problem